GUILIN TANG to Bortezomib
This is a "connection" page, showing publications GUILIN TANG has written about Bortezomib.
Connection Strength
0.028
-
Myeloid sarcoma as the initial presentation of chronic myelogenous leukemia, medullary chronic phase in era of tyrosine kinase inhibitors: A report of 11 cases. Am J Hematol. 2015 Aug; 90(8):E146-8.
Score: 0.028